Intellectus Partners’s Quince Therapeutics QNCX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.41K	Hold	267	–	–	﹤0.01%	287
2025 Q4	$179K	Buy	+267	New	+$134K	0.03%	277
2025 Q3	–	Sell	-267	Closed	-$88K	–	291
2025 Q2	$88K	Hold	267	–	–	0.02%	270
2025 Q1	$70.9K	Buy	+267	New	+$81.5K	0.02%	262
2024 Q4	–	Sell	-268	Closed	-$41.5K	–	284
2024 Q3	$41.5K	Buy	268 +1	+0.4%	+$143	0.01%	258
2024 Q2	$40K	Sell	267 -2	-0.7%	-$361	0.01%	254
2024 Q1	$57K	Buy	269 +1	+0.4%	+$248	0.02%	256
2023 Q4	$56.2K	Hold	268	–	–	0.02%	241
2023 Q3	$60K	Hold	268	–	–	0.02%	254
2023 Q2	$80.6K	Buy	+268	New	+$83.4K	0.02%	256
2022 Q1	–	Sell	-166	Closed	-$419K	–	259
2021 Q4	$419K	Sell	166 -48	-22%	-$293K	0.11%	191
2021 Q3	$3.93M	Buy	214 +47	+28%	+$747K	0.95%	17
2021 Q2	$1.77M	Buy	167 +57	+52%	+$478K	0.4%	62
2021 Q1	$794K	Buy	110 +40	+57%	+$288K	0.22%	136
2020 Q4	$388K	Buy	70 +43	+159%	+$381K	0.12%	178
2020 Q3	$265K	Buy	27 +1	+4%	+$9.1K	0.1%	182
2020 Q2	$241K	Buy	+26	New	+$238K	0.09%	190

Other funds holding QNCX